Compounds > fluphenazine

fluphenazine and naloxone

fluphenazine has been researched along with naloxone in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (25.00)	18.7374
1990's	1 (8.33)	18.2507
2000's	4 (33.33)	29.6817
2010's	4 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Strassburg, CP; Tukey, RH	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Beaumont, K; Fibiger, HC; Nagy, JI; Reisine, TD; Yamamura, HI	1
Perkins, MN; Stone, TW	1
Herman, ZS; Kowalski, J; Przewłocki, R; Trzeciak, H	1
Frydryszak, H; Polanski, E; Stoessl, AJ	1
McCormick, SE; Stoessl, AJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1

Reviews

3 review(s) available for fluphenazine and naloxone

Article	Year
Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annual review of pharmacology and toxicology, 2000, Volume: 40 Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic	2000
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
The opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia. Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:4 Topics: Animals; Antipsychotic Agents; Dyskinesia, Drug-Induced; Fluphenazine; Locomotion; Male; Mastication; Naloxone; Narcotics; Rats; Rats, Sprague-Dawley	1993

Other Studies

9 other study(ies) available for fluphenazine and naloxone

Article	Year
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
The localization of receptor binding sites in the substantia nigra and striatum of the rat. Brain research, 1979, Nov-16, Volume: 177, Issue:2 Topics: Animals; Brain Mapping; Corpus Striatum; Dihydroalprenolol; Fluphenazine; gamma-Aminobutyric Acid; Hydroxydopamines; Kainic Acid; Male; Muscimol; Naloxone; Neural Pathways; Neurons; Quinuclidinyl Benzilate; Rats; Receptors, Adrenergic, beta; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Neurotransmitter; Receptors, Opioid; Substantia Nigra	1979
Iontophoretic studies on pallidal neurones and the projection from the subthalamic nucleus. Quarterly journal of experimental physiology (Cambridge, England), 1981, Volume: 66, Issue:3 Topics: Animals; Dopamine; Fluphenazine; gamma-Aminobutyric Acid; Globus Pallidus; Glycine; Iontophoresis; Male; Mesencephalon; Naloxone; Neural Pathways; Neurons; Neurotransmitter Agents; Picrotoxin; Rats; Strychnine; Thalamic Nuclei	1981
Enkephalin content in rat striatum during prolonged treatment with fluphenazine. Neuropeptides, 1984, Volume: 4, Issue:6 Topics: Animals; Apomorphine; Corpus Striatum; Enkephalin, Leucine; Enkephalin, Methionine; Enkephalins; Fluphenazine; Male; Naloxone; Rats; Rats, Inbred Strains; Receptors, Dopamine	1984
Blockade of nigral and pallidal opioid receptors suppresses vacuous chewing movements in a rodent model of tardive dyskinesia. Neuroscience, 2002, Volume: 112, Issue:4 Topics: Animals; Dose-Response Relationship, Drug; Dynorphins; Dyskinesia, Drug-Induced; Fluphenazine; Globus Pallidus; Male; Mastication; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Somatostatin; Substantia Nigra	2002
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013